KPJ Healthcare Berhad (KLSE:KPJ)
2.930
+0.060 (2.09%)
At close: Feb 27, 2026
KPJ Healthcare Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 366.02 | 353.82 | 263.41 | 166.98 | 54.79 |
Depreciation & Amortization | 310.16 | 278.98 | 271.03 | 257.25 | 243.76 |
Other Amortization | 0.64 | 3.18 | 10.58 | 10.41 | 11.51 |
Loss (Gain) From Sale of Assets | -17.14 | 0.22 | -45.2 | -6.42 | 0.05 |
Asset Writedown & Restructuring Costs | 9.13 | 12.19 | 24.13 | -4.56 | 1.87 |
Loss (Gain) From Sale of Investments | - | - | - | - | 0.16 |
Loss (Gain) on Equity Investments | -48.76 | -49.36 | -46.76 | -47.76 | -25.86 |
Provision & Write-off of Bad Debts | 3.49 | 8.65 | 7.27 | -5.76 | 11.57 |
Other Operating Activities | 244.93 | 170.54 | 223.83 | 199.32 | 166.83 |
Change in Accounts Receivable | -26.66 | -89.7 | -33.18 | -171.56 | -54.22 |
Change in Inventory | -21.39 | -7.57 | -7.53 | -12.66 | -2.33 |
Change in Accounts Payable | 69.77 | 164.27 | -17.37 | 96.15 | 14.79 |
Change in Unearned Revenue | 3.03 | 0.2 | 39.07 | -2.23 | -5.06 |
Operating Cash Flow | 893.4 | 844.42 | 657.53 | 459.77 | 412.22 |
Operating Cash Flow Growth | 5.80% | 28.42% | 43.01% | 11.54% | 22.41% |
Capital Expenditures | -270.48 | -379.09 | -237.49 | -234.18 | -216.57 |
Sale of Property, Plant & Equipment | 241.1 | 1.83 | 22.32 | 195.27 | 0.73 |
Divestitures | -1.77 | 3.68 | 19.81 | - | 1.56 |
Sale (Purchase) of Intangibles | -6.87 | -0.14 | -3.01 | - | -0.19 |
Sale (Purchase) of Real Estate | - | - | - | - | -0.25 |
Investment in Securities | - | - | - | -25.01 | -0.5 |
Other Investing Activities | 50.75 | 141.66 | 103.77 | 38.12 | 252.98 |
Investing Cash Flow | 12.73 | -232.07 | -94.61 | -25.81 | 37.75 |
Long-Term Debt Issued | 107.48 | 108.37 | 707.64 | 840.76 | 235.29 |
Long-Term Debt Repaid | -344.55 | -508.07 | -833.16 | -951.25 | -497.26 |
Net Debt Issued (Repaid) | -237.07 | -399.7 | -125.52 | -110.5 | -261.98 |
Issuance of Common Stock | - | - | 19.18 | 14.9 | 42.88 |
Common Dividends Paid | -184.61 | -181.12 | -146.2 | -86.86 | -23.73 |
Other Financing Activities | -82.14 | 11.08 | -182.19 | -104.07 | -151 |
Financing Cash Flow | -503.82 | -569.73 | -434.73 | -286.54 | -393.82 |
Foreign Exchange Rate Adjustments | -1.38 | -0.82 | 7.45 | -0.53 | -1.2 |
Net Cash Flow | 400.93 | 41.8 | 135.64 | 146.89 | 54.95 |
Free Cash Flow | 622.92 | 465.33 | 420.04 | 225.59 | 195.65 |
Free Cash Flow Growth | 33.87% | 10.78% | 86.19% | 15.30% | 103.25% |
Free Cash Flow Margin | 14.63% | 11.86% | 12.29% | 7.86% | 7.55% |
Free Cash Flow Per Share | 0.14 | 0.11 | 0.10 | 0.05 | 0.04 |
Cash Interest Paid | - | 87.92 | 97.19 | 92.08 | 90.54 |
Cash Income Tax Paid | - | 182.42 | 76.42 | 92.04 | 58.94 |
Levered Free Cash Flow | 379.21 | 197.48 | 392.2 | 164.42 | -191.19 |
Unlevered Free Cash Flow | 500.69 | 320.61 | 520.25 | 285.87 | -86.98 |
Change in Working Capital | 24.75 | 67.21 | -19 | -90.31 | -46.81 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.